Literature DB >> 17229696

Mutations that decrease DNA binding of the processivity factor of the herpes simplex virus DNA polymerase reduce viral yield, alter the kinetics of viral DNA replication, and decrease the fidelity of DNA replication.

Changying Jiang1, Ying T Hwang, John C W Randell, Donald M Coen, Charles B C Hwang.   

Abstract

The processivity subunit of the herpes simplex virus DNA polymerase, UL42, is essential for viral replication and possesses both Pol- and DNA-binding activities. Previous studies demonstrated that the substitution of alanine for each of four arginine residues, which reside on the positively charged surface of UL42, resulted in decreased DNA binding affinity and a decreased ability to synthesize long-chain DNA by the polymerase. In this study, the effects of each substitution on the production of viral progeny, viral DNA replication, and DNA replication fidelity were examined. Each substitution mutant was able to complement the replication of a UL42 null mutant in transient complementation assays and to support the replication of plasmid DNA containing herpes simplex virus type 1 (HSV-1) origin sequences in transient DNA replication assays. Mutant viruses containing each substitution and a lacZ insertion in a nonessential region of the genome were constructed and characterized. In single-cycle growth assays, the mutants produced significantly less progeny virus than the control virus containing wild-type UL42. Real-time PCR assays revealed that these UL42 mutants synthesized less viral DNA during the early phase of infection. Interestingly, during the late phase of infection, the mutant viruses synthesized larger amounts of viral DNA than the control virus. The frequencies of mutations of the virus-borne lacZ gene increased significantly in the substitution mutants compared to those observed for the control virus. These results demonstrate that the reduced DNA binding of UL42 is associated with significant effects on virus yields, viral DNA replication, and replication fidelity. Thus, a processivity factor can influence replication fidelity in mammalian cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17229696      PMCID: PMC1866068          DOI: 10.1128/JVI.02359-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

Review 1.  Sliding clamps: a (tail)ored fit.

Authors:  M M Hingorani; M O'Donnell
Journal:  Curr Biol       Date:  2000-01-13       Impact factor: 10.834

2.  Mutations in yeast proliferating cell nuclear antigen define distinct sites for interaction with DNA polymerase delta and DNA polymerase epsilon.

Authors:  J C Eissenberg; R Ayyagari; X V Gomes; P M Burgers
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

3.  Processivity clamp gp45 and ssDNA-binding-protein gp32 modulate the fidelity of bacteriophage RB69 DNA polymerase in a sequence-specific manner, sometimes enhancing and sometimes compromising accuracy.

Authors:  Anna Bebenek; Geraldine T Carver; Farid A Kadyrov; Grace E Kissling; John W Drake
Journal:  Genetics       Date:  2005-02-03       Impact factor: 4.562

4.  Effects of substitutions of arginine residues on the basic surface of herpes simplex virus UL42 support a role for DNA binding in processive DNA synthesis.

Authors:  John C W Randell; Gloria Komazin; Changying Jiang; Charles B C Hwang; Donald M Coen
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Interaction between the herpes simplex virus type 1 origin-binding and DNA polymerase accessory proteins.

Authors:  S J Monahan; L A Grinstead; W Olivieri; D S Parris
Journal:  Virology       Date:  1998-02-01       Impact factor: 3.616

6.  Effects of exonuclease activity and nucleotide selectivity of the herpes simplex virus DNA polymerase on the fidelity of DNA replication in vivo.

Authors:  Y T Hwang; B Y Liu; C Y Hong; E J Shillitoe; C B Hwang
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

7.  Herpes simplex virus type 1 recombinants without the oriL sequence replicate DNA with increased fidelity.

Authors:  Changying Jiang; Ying T Hwang; Charles Bih-Chen Hwang
Journal:  Virology       Date:  2006-01-20       Impact factor: 3.616

8.  Saccharomyces cerevisiae pol30 (proliferating cell nuclear antigen) mutations impair replication fidelity and mismatch repair.

Authors:  C Chen; B J Merrill; P J Lau; C Holm; R D Kolodner
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

9.  Proliferating cell nuclear antigen promotes misincorporation catalyzed by calf thymus DNA polymerase delta.

Authors:  D J Mozzherin; M McConnell; M V Jasko; A A Krayevsky; C K Tan; K M Downey; P A Fisher
Journal:  J Biol Chem       Date:  1996-12-06       Impact factor: 5.157

10.  Herpes simplex virus processivity factor UL42 imparts increased DNA-binding specificity to the viral DNA polymerase and decreased dissociation from primer-template without reducing the elongation rate.

Authors:  K Weisshart; C S Chow; D M Coen
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more
  12 in total

1.  Herpes simplex virus mutants with multiple substitutions affecting DNA binding of UL42 are impaired for viral replication and DNA synthesis.

Authors:  Changying Jiang; Ying T Hwang; Guangliang Wang; John C W Randell; Donald M Coen; Charles B C Hwang
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

2.  Mutations that increase DNA binding by the processivity factor of herpes simplex virus affect virus production and DNA replication fidelity.

Authors:  Changying Jiang; Gloria Komazin-Meredith; Wang Tian; Donald M Coen; Charles B C Hwang
Journal:  J Virol       Date:  2009-05-27       Impact factor: 5.103

3.  Frequent release of low amounts of herpes simplex virus from neurons: results of a mathematical model.

Authors:  Joshua T Schiffer; Laith Abu-Raddad; Karen E Mark; Jia Zhu; Stacy Selke; Amalia Magaret; Anna Wald; Lawrence Corey
Journal:  Sci Transl Med       Date:  2009-11-18       Impact factor: 17.956

4.  The flexible loop of the human cytomegalovirus DNA polymerase processivity factor ppUL44 is required for efficient DNA binding and replication in cells.

Authors:  Gualtiero Alvisi; Daniela Martino Roth; Daria Camozzi; Gregory S Pari; Arianna Loregian; Alessandro Ripalti; David A Jans
Journal:  J Virol       Date:  2009-07-01       Impact factor: 5.103

5.  Finger domain mutation affects enzyme activity, DNA replication efficiency, and fidelity of an exonuclease-deficient DNA polymerase of herpes simplex virus type 1.

Authors:  Wang Tian; Ying T Hwang; Qiangsheng Lu; Charles B C Hwang
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

6.  Utilization of microsatellite polymorphism for differentiating herpes simplex virus type 1 strains.

Authors:  C Deback; D Boutolleau; C Depienne; C E Luyt; P Bonnafous; A Gautheret-Dejean; I Garrigue; H Agut
Journal:  J Clin Microbiol       Date:  2008-12-24       Impact factor: 5.948

7.  Herpes simplex virus 1 DNA polymerase processivity factor UL42 inhibits TNF-α-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1.

Authors:  Jie Zhang; Shuai Wang; Kezhen Wang; Chunfu Zheng
Journal:  Med Microbiol Immunol       Date:  2013-05-01       Impact factor: 3.402

Review 8.  Herpes simplex viruses: mechanisms of DNA replication.

Authors:  Sandra K Weller; Donald M Coen
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

9.  Live-Cell Analysis of Human Cytomegalovirus DNA Polymerase Holoenzyme Assembly by Resonance Energy Transfer Methods.

Authors:  Veronica Di Antonio; Giorgio Palù; Gualtiero Alvisi
Journal:  Microorganisms       Date:  2021-04-26

10.  Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract.

Authors:  Joshua T Schiffer; David Swan; Ramzi Al Sallaq; Amalia Magaret; Christine Johnston; Karen E Mark; Stacy Selke; Negusse Ocbamichael; Steve Kuntz; Jia Zhu; Barry Robinson; Meei-Li Huang; Keith R Jerome; Anna Wald; Lawrence Corey
Journal:  Elife       Date:  2013-04-16       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.